The abstract is read at the publisher; the summary is JClub's.
Chronic pulmonary aspergillosis (CPA) diagnosis is especially challenging in patients with concurrent or prior mycobacterial disease, where symptoms can be mistaken for smear/GeneXpert-negative pulmonary tuberculosis (PTB).
- Why it matters: Misdiagnosis matters because NTM, PTB, and CPA have different mortality and morbidity, yet clinicians often cannot distinguish recurrence, co-infection, or other differentials in resource-limited settings.
- What they did: The authors propose a new clinical algorithm to rule CPA in or out for newly diagnosed smear/GeneXpert-negative patients and for NTM patients, plus those with previous mycobacterial disease history.
- The result: They recommend follow-up screening—end-of-treatment TB chest X-rays and Aspergillus-specific IgG testing during and at the end of mycobacterial therapy—to enable earlier CPA diagnosis and reduce mortality and morbidity.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.